Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Yona Levites
Affiliation
Emory University School of Medicine
ORCID
Career Start Year
2001
Papers
56
H Index
28
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38076912
Aβ Amyloid Scaffolds the Accumulation of Matrisome and Additional Proteins in Alzheimer's Disease.
bioRxiv
2023
38027063
A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-Aβ scFvs: Applications for gene therapies.
Mol Ther Methods Clin Dev
2023
35328748
Intracerebral but Not Peripheral Infection of Live <i>Porphyromonas gingivalis</i> Exacerbates Alzheimer's Disease Like Amyloid Pathology in APP-TgCRND8 Mice.
Int J Mol Sci
2022
35352880
AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model.
EMBO Mol Med
2022
35494163
Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse Aβ plaque pathology when injected into newborn mouse hosts.
Free Neuropathol
2022
33480174
Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease.
Alzheimers Dement
2021
33741985
Il-10 signaling reduces survival in mouse models of synucleinopathy.
NPJ Parkinsons Dis
2021
33508158
Biophysical characteristics of lipid-induced Aβ oligomers correlate to distinctive phenotypes in transgenic mice.
FASEB J
2021
33833060
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.
Proc Natl Acad Sci U S A
2021
33957936
Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy.
Mol Neurodegener
2021
33128896
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes.
Mol Ther
2021
32252825
Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
Acta Neuropathol Commun
2020
33069251
Aÿ40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aÿ42 toxicity in Drosophila.
Alzheimers Res Ther
2020
32665013
Fyn depletion ameliorates tau<sup>P301L</sup>-induced neuropathology.
Acta Neuropathol Commun
2020
32668255
Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models.
Cell Rep
2020
32122372
Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.
Mol Neurodegener
2020
31109378
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
Acta Neuropathol Commun
2019
31685865
Intra- and extracellular β-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus.
Sci Rep
2019
31472250
Neurite orientation dispersion and density imaging reveals white matter and hippocampal microstructure changes produced by Interleukin-6 in the TgCRND8 mouse model of amyloidosis.
Neuroimage
2019
31467037
An anti-CRF antibody suppresses the HPA axis and reverses stress-induced phenotypes.
J Exp Med
2019
30770411
rAAV-based brain slice culture models of Alzheimer's and Parkinson's disease inclusion pathologies.
J Exp Med
2019
29208777
Short Aβ peptides attenuate Aβ42 toxicity in vivo.
J Exp Med
2018
30261006
Designing antibodies against LRRK2-targeted tau epitopes.
PLoS One
2018
29608591
Novel monoclonal antibodies targeting the microtubule-binding domain of human tau.
PLoS One
2018
28760159
Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.
Acta Neuropathol Commun
2017
28098204
Strain-specific Fibril Propagation by an Aβ Dodecamer.
Sci Rep
2017
27531960
Holdase activity of secreted Hsp70 masks amyloid-β42 neurotoxicity in Drosophila.
Proc Natl Acad Sci U S A
2016
26418152
Deficits in hippocampal-dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis.
Hippocampus
2016
25228069
Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
Mol Ther
2015
26253732
Anti-Aβ single-chain variable fragment antibodies exert synergistic neuroprotective activities in Drosophila models of Alzheimer's disease.
Hum Mol Genet
2015
26156074
IFN-γ promotes Ͽ phosphorylation without affecting mature tangles.
FASEB J
2015
25904780
A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.
J Neurosci
2015
25286085
Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction.
J Vis Exp
2014
23347239
Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo.
Eur J Neurosci
2013
24252149
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein.
Acta Neuropathol Commun
2013
23825679
Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain.
PLoS One
2013
23666556
Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy.
Acta Neuropathol
2013
22156046
Bispecific tandem single chain antibody simultaneously inhibits β-secretase and promotes α-secretase processing of AβPP.
J Alzheimers Dis
2012
22910355
Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo.
Nat Commun
2012
22621179
Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains.
Alzheimers Res Ther
2012
21073877
Inhibiting β-secretase activity in Alzheimer's disease cell models with single-chain antibodies specifically targeting APP.
J Mol Biol
2011
19825975
Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition.
FASEB J
2010
19275635
Quantitative and mechanistic studies of Abeta immunotherapy.
CNS Neurol Disord Drug Targets
2009
19638957
Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease.
Mol Ther
2009
18524908
BRI2 (ITM2b) inhibits Abeta deposition in vivo.
J Neurosci
2008
17611268
Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis.
J Neurosci
2007
16341263
Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.
J Clin Invest
2006
17108166
Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice.
J Neurosci
2006
17068112
Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models.
FASEB J
2006
16872492
Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy.
J Neuroinflammation
2006
1 - 50 of 56
Column Actions
Search
Recommended Authors
Mathieu Bourdenx
University College London, UK Dementia Research Institute
Career Start Year
2013
Number of shared co-authors
1
Rachel E Bennett
Massachusetts General Hospital, Harvard Medical School
Career Start Year
2011
Number of shared co-authors
2
Chao Wang
Gladstone Institutes
Career Start Year
2011
Number of shared co-authors
1
Eloise Hudry
Massachusetts General Hospital/Harvard Medical School
Career Start Year
2010
Number of shared co-authors
2
Carlo Condello
UCSF Weill Institute for Neurosciences, University of California san francisco
Career Start Year
2007
Number of shared co-authors
0
Sakura Minami
Dokkyo Medical University
Career Start Year
2006
Number of shared co-authors
1
Yaqiao Li
Harvard Medical School
Career Start Year
2005
Number of shared co-authors
2
Yungui Zhou
Gladstone Institutes
Career Start Year
2001
Number of shared co-authors
2
Markus Britschgi
Roche Pharma Research and Early Development
Career Start Year
1999
Number of shared co-authors
2
Li Gan
Helen and Robert Appel Alzheimer's Disease Research Institute
Career Start Year
1999
Number of shared co-authors
3
Christopher Dirk Keene
University of Washington
Career Start Year
1998
Number of shared co-authors
23
Fiona Grueninger
Roche Pharma Research and Early Development (pRED)
Career Start Year
1996
Number of shared co-authors
0
Suman Jayadev
University of Washington
Career Start Year
1995
Number of shared co-authors
15
Hyemyung Seo
Center for Bionano Intelligence Education and Research, Hanyang University
Career Start Year
1995
Number of shared co-authors
2
Tony Wyss-Coray
Stanford University
Career Start Year
1992
Number of shared co-authors
7
Claudio Soto
University of Texas McGovern Medical School at Houston
Career Start Year
1992
Number of shared co-authors
3
Steven W Barger
University of Arkansas for Medical Sciences
Career Start Year
1989
Number of shared co-authors
0
Thomas J Montine
Stanford University
Career Start Year
1988
Number of shared co-authors
28
Steven Finkbeiner
J. David Gladstone Institutes
Career Start Year
1988
Number of shared co-authors
3
Henry W Querfurth
Tufts Medical Center and Neuroscience, Tufts University
Career Start Year
1987
Number of shared co-authors
4
Eliezer Masliah
National Institute On Aging
Career Start Year
1986
Number of shared co-authors
32
Matthew P Frosch
Massachusetts General Hospital and Harvard Medical School
Career Start Year
1984
Number of shared co-authors
23
Dean M Hartley
Rush University Medical Center
Career Start Year
1983
Number of shared co-authors
1
Lennart Mucke
Gladstone Institute of Neurological Disease, Gladstone Institutes
Career Start Year
1982
Number of shared co-authors
4
Christian Haass
German Center for Neurodegenerative Diseases (DZNE) Munich
Career Start Year
1981
Number of shared co-authors
8
Michael P Vitek
Duke University Medical Center
Career Start Year
1981
Number of shared co-authors
1
Raymond S Turner
Georgetown University
Career Start Year
1981
Number of shared co-authors
7
Virginia M-Y Lee
Perelman School of Medicine at the University of Pennsylvania
Career Start Year
1977
Number of shared co-authors
19
John Q Trojanowski
University of Pennsylvania
Career Start Year
1974
Number of shared co-authors
33
George Perry
College of Sciences, The University of Texas at San Antonio
Career Start Year
1970
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Todd E Golde
Emory Center for Neurodegenerative Disease
Co-authored papers
41
Paramita Chakrabarty
Center for Translational Research in Neurodegenerative Disease, University of Florida
Co-authored papers
17
Pedro E Cruz
College of Medicine, University of Florida
Co-authored papers
12
Carolina Ceballos-Diaz
Center for Translational Research in Neurodegenerative Disease, University of Florida
Co-authored papers
11
Dennis W Dickson
Mayo Clinic Jacksonville
Co-authored papers
8
Pritam Das
Institute of Medical Sciences, Banaras Hindu University
Co-authored papers
7
Brenda D Moore
College of Medicine, University of Florida
Co-authored papers
7
Christopher Janus
College of Medicine, University of Florida
Co-authored papers
4
Diego E Rincon-Limas
University of Florida
Co-authored papers
4
Cory C Funk
Institute for Systems Biology
Co-authored papers
4
Nil??fer Ertekin-Taner
Mayo Clinic
Co-authored papers
4
Awilda M Rosario
Center for Translational Research in Neurodegenerative Disease, University of Florida
Co-authored papers
4
Eric B Dammer
Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine
Co-authored papers
3
Xue Wang
Mayo Clinic
Co-authored papers
3
Mariet Allen
Mayo Clinic
Co-authored papers
3
Karen N McFarland
Center for Translational Research in Neurodegenerative Disease, University of Florida
Co-authored papers
3
Allan I Levey
Emory University School of Medicine
Co-authored papers
3
Nathan D Price
Institute for Systems Biology
Co-authored papers
3
Edna Grünblatt
Co-authored papers
2
Nadia DiNunno
College of Medicine, Penn State College of Medicine
Co-authored papers
2
Steven G Younkin
Mayo Clinic
Co-authored papers
2
Andrew Li
Center for Translational Research in Neurodegenerative Disease, University of Florida
Co-authored papers
2
Kevin H Strang
College of Medicine, University of Florida
Co-authored papers
2
Minerva M Carrasquillo
Mayo Clinic
Co-authored papers
2
Amanda N Sacino
Johns Hopkins University School of Medicine
Co-authored papers
2
Christophe Verbeeck
Mayo Clinic College of Medicine
Co-authored papers
2
Jungwoo Wren Kim
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Co-authored papers
1
James J Lah
Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine
Co-authored papers
1
David A Bennett
Rush University Medical Center
Co-authored papers
1
Ying-Wooi Wan
Baylor College of Medicine
Co-authored papers
1
1 - 30